Clinical Trial

A Multicenter Prospective Observational Cohort Study Evaluating the Impact of Cancer-Directed Treatment and Medication Use, Including Cannabis Use, in Multiple Myeloma Patients

Recruiting
View on ClinicalTrials.gov →
Summary
This study assesses the impact of cannabis (also commonly called marijuana, weed, or THC) use on quality of life among patients with multiple myeloma who are receiving chemotherapy. It also evaluates the potential benefits and harms of cannabis use.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-11-05; most recent amendment 2026-02-18.
Status change: Not Yet Recruiting → Recruiting 2026-02-18
Trial Details
NCT Number NCT07225738
Lead Sponsor City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions Multiple Myeloma
Enrollment 700 participants
Start Date 2026-01-21
Primary Completion 2030-08-22 (estimated)
Study Completion 2030-08-22 (estimated)
Updated on ClinicalTrials.gov 2026-02-20